Differential 17-Oxosteroid Excretion in Women with Cancer of the Breast Following Hypophysectomy
1964

Study of 17-Oxosteroid Excretion in Women with Breast Cancer After Hypophysectomy

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): A. A. Khattab, D. N. Baron

Primary Institution: Department of Chemical Pathology, The Royal Free Hospital

Hypothesis

Does hypophysectomy affect the excretion of 17-oxosteroids in women with breast cancer?

Conclusion

After complete hypophysectomy, dehydroepiandrosterone was not found in urine, but androsterone and aetiocholanolone continued to be excreted.

Supporting Evidence

  • 17-oxosteroid excretion was low before hypophysectomy but qualitatively normal.
  • Dehydroepiandrosterone was absent in urine after complete hypophysectomy.
  • Androsterone and aetiocholanolone continued to be excreted post-hypophysectomy.

Takeaway

The study looked at how a surgery called hypophysectomy affects certain hormones in women with breast cancer. It found that one hormone disappeared after the surgery, but two others were still present.

Methodology

Patients underwent hypophysectomy, and their urinary 17-oxosteroid excretion was analyzed pre- and post-surgery.

Limitations

The study faced challenges in accurately measuring 17-oxosteroid levels due to low output and interference from pigments in urine.

Participant Demographics

All patients were suffering from carcinoma of the breast, mostly post-menopausal or ovariectomized.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication